Clinical Trial Update: Goal Directed Ammonia Lowering Therapy in Hyperammonemic ACLF Patients With no Overt HE to Reduce Major Adverse Liver Related Outcomes (GOAL Trial) [NA]

View source ↗

Summary

This document describes the GOAL Trial, a clinical study assessing an ammonia-lowering therapy in patients with acute-on-chronic liver failure and hyperammonemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Goal Directed Ammonia Lowering Therapy

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Acute on Chronic Liver Failure | NA | Status: NOT_YET_RECRUITING